FindTrial
Sign In

Pertussis in Chronic Obstructive pulmonary disease patients

Burden and Impact of pertussis in patients with COPD Exacerbation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050495
Enrollment
170
Registered
2023-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

None listed

Sponsors

Rajarajeswari medical college & Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to RRMCH with acute exacerbation of COPD

Exclusion criteria

Exclusion criteria: Patients of lung cancer, bronchiectasis, pneumoconiosis or other simple restriction ventilation dysfunction, asthma, Allergic Rhinitis, active TB, Pulmonary Embolism, Cystic Fibrosis, Alpha 1 anti-trypsin deficiency. Patients who have undergone lung resection. Patients on immunosuppressive medications.

Design outcomes

Primary

MeasureTime frame
1. Evaluate the Prevalence and Impact of pertussis in patients with COPD acute exacerbations. 2. Evaluate correlation between pertussis and COPD exacerbations Timepoint: 6 months—

Secondary

MeasureTime frame
Evaluating the spirometry values in COPD patients with pertussis Evaluating exacerbation rates in these patientsTimepoint: 6 months—

Countries

India

Contacts

Public ContactArchana Baburao

Rajarajeswari Medical college and Hospital

dr_archana82@yahoo.co.in09741016606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026